Latest blog posts
qSOA® facilitates the development of industry-ready hybrid software systems
The development of industry-ready quantum software solutions is, and will long be, hybrid, given the compelling need to dynamically connect classical software with quantum software solutions. Successfully designing, developing, and implementing these hybrid...
AWS Webinar: Quantum Software Engineering with QuantumPath® on AWS Braket
As part of the AWS (Amazon Web Services) events, José Luis Hevia, Founder & CTO of aQuantum together with Nihit Pokhrel, Partner Solutions Architect, HPC at Amazon Web Services (AWS), have presented the video: “Software Engineering with QuantumPath® with AWS” In...
Quantum Software Components and Platforms: Overview and Quality Assessment
Manuel Serrano, José Antonio Cruz, Ricardo Pérez, and Mario Piattini, members of aQuantum has just published the paper “Quantum software components and platforms: overview and quality assessment” in the journal ACM Computing Surveys of the Association for Computing...
aQuantum Gates
QuantumPath Demos
QPath, the first quantum development & application lifecycle platform
Talking about QPath, the quantum development & aplication lifecycle platform
Introduction to agnostic quantum software development with QPath
Developing classical/quantum hybrid software with QPath
Talavera Manifesto
This Manifesto collects some principles and commitments about the quantum software engineering and programming field,
as well as some calls for action.
aQuantum courses
Courses designed by aQuantum for quantum programmers
Learn more about aQuantum courses
Ask for information
Contact us and recieve more information about quantum software engineering and programming.
They talk about us
“QuantumPath, The First Quantum Software Development and Application Lifecycle Platform, is an ecosystem that covers the widest range of possible applications by integrating the software classical and quantum worlds, developing quantum software connected to real-world systems”.
“The general aim of project “QHealth: Quantum pharmacogenomics applied to ageing” is mainly human-oriented: the increase in longevity and quality of life of older adults. The study will include the adverse reactions to prescribing drugs in order to predict unwanted side effects of a specific one”.
